Se Habla Español Category Archives: Mesothelioma
Johnson & Johnson discussed possible asbestos contamination
In the past few years, there has been a surge of lawsuits filed against Johnson & Johnson, a well-known and respected brand, for asbestos exposure and related cancers. Plaintiffs claim that due to contaminated baby powder products, they were at…
Pursuing compensation for victims of mesothelioma
Mesothelioma is an aggressive form of cancer that is caused by asbestos exposure. Many victims will live for decades without a disease diagnosis because they do not exhibit mesothelioma symptoms. By the time they are diagnosed with peritoneal or pleural…
Number of annual mesothelioma deaths on the rise
Malignant mesothelioma is a disease often contracted from occupational exposure to asbestos. The latency period for the disease is approximately 20 to 40 years, sometimes as long as 71 years. Therefore, despite increased regulation of asbestos, more North Carolinians are…
Study confirms diet has impact on mesothelioma survival
North Carolinians would likely be interested in a new mesothelioma study. The study, conducted by Johns Hopkins and Drexel University, reveals that survivors of mesothelioma and other cancers may not be following appropriate dietary guidelines to increase their survivability. Participants…
Mesothelioma Awareness Day
Mesothelioma Awareness Day, established by Meso Foundation community members, will take place on September 26 for the 13th year in a row. The campaign is designed to bring awareness and funding to mesothelioma, a disease that claims the lives of…
Study confirms benefits of trimodal treatment for mesothelioma
A recent study by researchers at the MD Anderson Cancer Center confirms what many North Carolina residents suffering from mesothelioma already know — mesothelioma patients benefit greatly from undergoing several forms of treatment. The study’s researchers found that post-disease diagnosis…
Clinical trial for pleural mesothelioma drug ends
Mesothelioma patients may be disappointed to learn that a trial of a new mesothelioma drug, anetumab ravtansine, was stopped after the drug was proven to be less effective than an existing drug, vinorelbine. The results of Bayer’s Phase II clinical…
The benefits of robotic EPP for mesothelioma patients
Treatments for mesothelioma have become more abundant and more advanced in the last ten years. While there is still no cure, patients are living longer and studies into new treatments have provided encouraging results. One controversial procedure may be more…
Time between mesothelioma surgeries indicative of longer survival
North Carolina residents may be interested to hear that recently, cancer researchers analyzed patients with peritoneal surface cancers to determine if the interval between cytoreductive surgeries with heated hyperthermic intraperitoneal chemotherapy is a marker for survival. Fourteen percent of patients…
Recent FDA approval may be promising for lung cancer patients
A previous blog post discussed an ongoing trial (Keynote-028) of a promising new treatment for mesothelioma. The study aimed to examine the effects of Keytruda, a checkpoint inhibitor immunotherapy drug, on patients with mesothelioma. The U.S. Food and Drug Administration…
Get Help Today
Fields marked with an * are required
SERVING
LOCATIONS
NATIONWIDE
contact us
© 2025 by Mesothelioma Lawyer All rights reserved.
Digital Marketing By 